FDA Approval The latest news regarding FDA applications, processes, and approval. This section contains releases regarding the Food and Drug Administration’s consideration of new products, drugs, therapies and treatments. Find announcements covering every stage of the FDA application process, from filing to eventual approval, including appeals, resubmissions, and safety alerts.

Feb 04, 2015

08:00 ET

Feb 04, 2015

08:00 ET

Feb 04, 2015

08:00 ET

Koning Corporation

Feb 04, 2015

07:00 ET

Sangamo BioSciences, Inc.

Feb 03, 2015

11:00 ET

Feb 03, 2015

10:12 ET

Feb 03, 2015

07:00 ET

Afrezza(R) Inhaler with 8 unit and 4 unit cartridges of Afrezza (insulin human) Inhalation Powder.

Feb 03, 2015

04:22 ET

Zeltia Logo

Feb 03, 2015

03:30 ET

Feb 03, 2015

03:30 ET

Zeltia Logo

Feb 03, 2015

03:30 ET

Zeltia Logo

Feb 02, 2015

15:00 ET

Feb 02, 2015

12:46 ET

Feb 02, 2015

11:00 ET

Feb 02, 2015

09:00 ET

Feb 02, 2015

08:30 ET

Glyxambi® (empagliflozin/linagliptin) tablet packaging 10/5 mg (left). Glyxambi® (empagliflozin/linagliptin) tablet packaging 25/5 mg (right)

Feb 02, 2015

08:30 ET

Feb 02, 2015

08:30 ET

Feb 02, 2015

07:00 ET

CytoSorbents Logo.

Feb 02, 2015

06:30 ET

IRIDEX Corporation logo.

Jump to news releases